4DMedical Limited FDMDF
1.95 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
2.40 Day range 2.40
0.8701 52-week range 5.00
- YTD
- -17.02%
- 1 year
- +74.11%
News
seekingalpha.com 4DMedical Limited (FDMDF) Shareholder/Analyst Call Transcript 4DMedical Limited (FDMDF) Shareholder/Analyst Call Transcript
seekingalpha.com 4DMedical Limited (FDMDF) M&A Call Transcript 4DMedical Limited (FDMDF) M&A Call Transcript
seekingalpha.com 4DMedical Limited (FDMDF) Discusses Clinical Use of CT:VQ in Patient Selection for Lung Volume Reduction Surgery Transcript 4DMedical Limited (FDMDF) Discusses Clinical Use of CT:VQ in Patient Selection for Lung Volume Reduction Surgery Transcript
prnewswire.com 4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 30,…
prnewswire.com 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego…
seekingalpha.com 4DMedical Limited (FDMDF) Discusses Imaging Technology Portfolio and Market Positioning in Cardio-Pulmonary Diagnostics Transcript 4DMedical Limited (FDMDF) Discusses Imaging Technology Portfolio and Market Positioning in Cardio-Pulmonary Diagnostics Transcript
seekingalpha.com 4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript 4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript
seekingalpha.com 4DMedical Limited - Special Call 4DMedical Limited - Special Call Company Participants Andreas Fouras - Founder, MD, CEO & Director Conference Call Participants Thomas Godfrey - Ord Minnett Limited, Research Division Kyle Hogarth…
prnewswire.com 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES , Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in…